Vasculitis occurring during leflunomide therapy

Elisabeth A. Holm; E. Balslev; G. B.E. Jemec

doi:10.1159/000051761

Vasculitis occurring during leflunomide therapy

Elisabeth A. Holm^*, E. Balslev, G. B.E. Jemec

^*Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstract

Leflunomide has recently been introduced for systemic treatment of rheumatoid arthritis. It has both immunosuppressive effects and anti-inflammatory properties. We report a patient treated with leflunomide who developed vasculitis as an adverse side effect. As far as we are aware, this is the first published report of vasculitis associated with leflunomide therapy.

Originalsprog	Engelsk
Sider (fra-til)	258-259
Antal sider	2
Tidsskrift	Dermatology
Vol/bind	203
Udgave nummer	3
DOI	https://doi.org/10.1159/000051761
Status	Udgivet - 17 nov. 2001

Adgang til dokumentet

10.1159/000051761

Andre filer og links

http://www.scopus.com/inward/record.url?scp=0034759742&partnerID=8YFLogxK

Citationsformater

@article{add67ccd744447a4a2a04b8555c65051,

title = "Vasculitis occurring during leflunomide therapy",

abstract = "Leflunomide has recently been introduced for systemic treatment of rheumatoid arthritis. It has both immunosuppressive effects and anti-inflammatory properties. We report a patient treated with leflunomide who developed vasculitis as an adverse side effect. As far as we are aware, this is the first published report of vasculitis associated with leflunomide therapy.",

keywords = "Drug side effect, Leflunomide, Rheumatoid arthritis, Vasculitis",

author = "Holm, {Elisabeth A.} and E. Balslev and Jemec, {G. B.E.}",

year = "2001",

month = nov,

day = "17",

doi = "10.1159/000051761",

language = "English",

volume = "203",

pages = "258--259",

journal = "Dermatology",

issn = "1018-8665",

publisher = "S. Karger AG",

number = "3",

}

TY - JOUR

T1 - Vasculitis occurring during leflunomide therapy

AU - Holm, Elisabeth A.

AU - Balslev, E.

AU - Jemec, G. B.E.

PY - 2001/11/17

Y1 - 2001/11/17

N2 - Leflunomide has recently been introduced for systemic treatment of rheumatoid arthritis. It has both immunosuppressive effects and anti-inflammatory properties. We report a patient treated with leflunomide who developed vasculitis as an adverse side effect. As far as we are aware, this is the first published report of vasculitis associated with leflunomide therapy.

AB - Leflunomide has recently been introduced for systemic treatment of rheumatoid arthritis. It has both immunosuppressive effects and anti-inflammatory properties. We report a patient treated with leflunomide who developed vasculitis as an adverse side effect. As far as we are aware, this is the first published report of vasculitis associated with leflunomide therapy.

KW - Drug side effect

KW - Leflunomide

KW - Rheumatoid arthritis

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=0034759742&partnerID=8YFLogxK

U2 - 10.1159/000051761

DO - 10.1159/000051761

M3 - Article

C2 - 11701983

AN - SCOPUS:0034759742

SN - 1018-8665

VL - 203

SP - 258

EP - 259

JO - Dermatology

JF - Dermatology

IS - 3

ER -

Vasculitis occurring during leflunomide therapy

Abstract

Adgang til dokumentet

Andre filer og links

Fingeraftryk

Citationsformater